DUPHAT Conference

What is it all about?

Dubai International Pharmaceutical & Technology Conference & Exhibition- DUPHAT is finally around the corner. Started in 1955 as a concept to support the local markets, DUPHAT has now established itself as a leading regional educational brand and networking platform for worldwide pharma tycoons.

More than 960 brands and exhibiting companies will be seen taking part in the largest unmissable event in the MENA region. The event will witness 22K plus visits from more than 75 countries and will be marked by the presence of 140+ speakers from different countries.

DelveInsight is attending the event to cover the multiple sessions, workshops and to network with industry experts and Key Opinion Leaders to explore business opportunities and knowledge sharing.

It will help our team to learn from various medical practitioners, scientists, industry leaders, researchers, and peers from the MENA region. The delveInsight team will gather valuable insights and take into account the latest industry innovations and findings, which will be incorporated into upcoming market research.

Do not miss the opportunity to connect with DelveInsight’s team at DUPHAT 2022 and to attend the leading healthcare event of the MENA region. We’ll be waiting for you. Simply connect to us by filling up the form on the right.

Counting Down

10 – 12 January 2023 | Dubai World Trade Center

Market Research & Analysis

DelveInsight offers comprehensive analysis to Pharma and biotech goliaths about the market trends in the emerging geographies exclusively focused on the MENA region. We help clients to identify untapped and lucrative opportunities to grab. On the same line, DelveInsight strategizes the business decisions of local pharma players to establish themselves in major markets, including the seven major geographies.

Exclusively focused Rare disease analysis

Rare genetic diseases have been shown to express a significant burden globally, with a significant effect on the MENA region. With an exclusive focus on the Rare disease market, DelveInsight highlights primary and secondary reasons- genetic, lifestyle, and environmental- behind the increasing prevalence of Rare diseases in the MENA. Moreover, this gives pharma and biotech players – local and international- an opportunity to expand their regional portfolio and manufacturing units.

Support across the drug value chain

DelveInsight provides consulting services- that give its clients a competitive edge, providing them with support in the therapy development process from the pre-clinical phase until the therapy enters the market. Moreover, consultants at DelveInsight, with their expertise and experience, help companies to keep themselves prepared for the unexpected challenges that bump into the course of the journey.

Business expansion, Partnering & Licensing opportunities

To sustain in this fast-evolving Life Science market, companies in the Life Science vertical – Small, Medium, and Large – need to expand their business, which is why Mergers, Acquisitions, and Partnering opportunities are ordinarily happening. However, the move requires a lot of brainstorming, market analysis, and intense competitive studies, with which DelveInsight possesses the potential to help. With the vast knowledge of the market - Major and Emerging - and a good number of global clients served, DelveInsight helps local companies to get acquainted with international ones and vice versa, thus facilitating business partnering and expansions.

Regulatory guidelines & Pricing Analysis

With the different regulatory bodies in foreign markets - governing drug approvals and clinical trial guidelines – it becomes quite difficult for pharma players to keep themselves abreast of policy changes. DelveInsight helps its clients diligently lay out specific changes that may boost or hinder their product in the market, along with pricing strategies to yield a better investment return.

We welcome you to discuss your business-related concerns, and we can together find the best possible solution to help you proceed further in the healthcare market.

    Stuti Mahajan

    Stuti Mahajan holds a masters in biotechnology, has more than 6 years of experience in healthcare consulting, and has executed and managed more than 50 consulting & CI projects. She has rich experience in pipeline analytics, market intelligence, and business research in pharma, biotech & medical device industries with managing client expectations on project outcomes. She specializes in opportunity assessment, disease landscaping, indication/asset prioritization, clinical trial analytics, project sustainability & feasibility study, and more.

  • Assistant MANAGER, Business Development
    Harshita Verma

    Harshita holds an MBA degree in Marketing Management with an experience of 5 years working in pharmaceutical industry. Currently, she is working as assistant manager business development in pharmaceutical and life sciences domain. She has a experience in assisting clients through advisory services in the areas of R&D, Strategy Formulation, Competitive Intelligence, Competitive Landscaping, partnering, and Mergers & Acquisitions. Apart from these, she worked and communicated with clients in APAC, US and European markets and managed client accounts and maintaining customer relationships. She specialized in assisting client needs based on current objectives, supply and demand, and seasonal variables. Over a short period of time she has successfully steered the organization’s growth through actively reaching out to prospective leads and addressing their needs. Moreover, she has an in-dpeth understanding of the client’s requirements and successfully delivered customized solutions across different therapeutic areas.

Organized by INDEX conferences and Exhibitions, the conference is going to take place at Dubai International Convention Centre, Dubai, UAE, from 10 – 12 January 2023.

Counting Down
10 – 12 January 2023

Get in Touch with Us